UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Pilot Study of Immunological Response to PSMA-Directed Radioligand Therapy for the Treatment of Oligometastatic Prostate Cancer

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e593-e594

2024

Volltextzugriff (PDF)

Predictive Value of Genomic Classifier Scores and Transcriptomic Data for Prostate Cancer Distant Metastasis Risk: A Multicenter Retrospective Study

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e423-e424

2023

Volltextzugriff (PDF)

Clinical Usefulness of PSMA PET/CT Imaging in Patients with Suspected Recurrence of Prostate Cancer after Primary RT with PSA below the Phoenix Criteria Threshold: Systematic Review and Meta-Analysis

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e387-e387

2023

Volltextzugriff (PDF)

Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials

International journal of radiation oncology, biology, physics, 2023-08, Vol.116 (5), p.1079-1084

2023

Volltextzugriff (PDF)

French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC)

International journal of radiation oncology, biology, physics, 2006-03, Vol.64 (4), p.983-994

2006

Volltextzugriff (PDF)

Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post-Hoc Analysis of Two Prospective Ga-68-PSMA PET/CT Imaging Trials

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e294-e294

2021

Volltextzugriff (PDF)

Prognostic Significance of the Risk of Non-localized Disease on PSMA/PET: Comparative Performance of a Novel, PSMA/PET-Derived Risk Stratification Tool for High-Risk Prostate Cancer in a Large, Multi-Institutional Cohort

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.S51-S52

2021

Volltextzugriff (PDF)

Stereotactic Radiation Therapy (SRT) for Metastatic Renal Cell Carcinoma (mRCC)

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E247-E248

2016

Volltextzugriff (PDF)

Concurrent Chemoradiation Therapy Versus Acceleration of Radiation Therapy With or Without Concurrent Chemotherapy in Locally Advanced Head and Neck Carcinoma (GORTEC 99-02): 7-Year Survival Data From a Phase 3 Randomized Trial and Prognostic Factors

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E324-E325

2016

Volltextzugriff (PDF)

Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems

International journal of radiation oncology, biology, physics, 2003, Vol.55 (1), p.93-98

2003

Volltextzugriff (PDF)

Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial

International journal of radiation oncology, biology, physics, 2004, Vol.58 (1), p.161-166

2004

Volltextzugriff (PDF)

Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications

International journal of radiation oncology, biology, physics, 1997-02, Vol.37 (3), p.619-627

1997

Volltextzugriff (PDF)

Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for stages IIB and III esophageal carcinoma: Results of a pilot study

International journal of radiation oncology, biology, physics, 1997-07, Vol.38 (4), p.769-775

1997

Volltextzugriff (PDF)

Subcutaneous (SbQ) Versus Intravenous (IV) Administration of Amifostine for Head and Neck (HN) Cancer Patients Receiving Radiotherapy (RT): Preliminary Results of the GORTEC 2000–02 Randomized Trial

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S127-S127

2005

Volltextzugriff (PDF)

Late toxicity results of randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma (GORTEC 94-01)

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.39-39

2001

Volltextzugriff (PDF)

Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma. final results of the 94-01 GORTEC randomized study

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.1-2

2001

Volltextzugriff (PDF)

Predictive factors for late toxic effects following high dose rate brachytherapy (HDRB) boost for esophageal cancer (EC)

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.266-266

2001

Volltextzugriff (PDF)

Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma

International journal of radiation oncology, biology, physics, 2002-10, Vol.54 (2), p.57-58

2002

Volltextzugriff (PDF)

Primary chemotherapy and radiosurgical breast-conserving treatment for patients with locally advanced operable breast cancers

International journal of radiation oncology, biology, physics, 1993-04, Vol.26 (1), p.37-42

1993

Volltextzugriff (PDF)

2179 Radiation therapy with concomitant weekly docetaxel in stages III and IV non metastatic oral cavity and oropharynx carcinomas. Results of the gortec 98-02 phase II study

International journal of radiation oncology, biology, physics, 1999, Vol.45 (3), p.370-370

1999

Volltextzugriff (PDF)

Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma. Results of the 94.01 randomized study from the french group of radiation oncology for head and neck cancer (Gortec)

International journal of radiation oncology, biology, physics, 1998, Vol.42 (1), p.145-145

1998

Volltextzugriff (PDF)

Preoperative or postoperative brachytherapy for patients with endometrial carcinoma stage I and II

International journal of radiation oncology, biology, physics, 1990-09, Vol.19 (3), p.523-527

1990

Volltextzugriff (PDF)

Radical hysterectimy for stage I and II endometrial carcinoma : a retrospective analysis of 179 cases

International journal of radiation oncology, biology, physics, 1991, Vol.20 (4), p.677-683

1991

Volltextzugriff (PDF)

Carcinoma of the uretine cervix stabe IB and early stage II. Prognostic value of the histological tumor regression after initial brachytherapy

International journal of radiation oncology, biology, physics, 1989, Vol.17 (6), p.1231-1235

1989

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieInternational Journal Of Radiation Oncology, Biology, Physics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(1)

Erscheinungsjahr

n.n

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(24)
Ingenta
(24)
Elsevier ScienceDirect Journals Complete
(24)
MEDLINE
(7)
IngentaConnect Journals
(4)

Zeitschrift / Serie

International Journal Of Radiation Oncologybiologyphysics
(1)

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A Pilot Study of Immunological Response to PSMA-Directed Radioligand Therapy for the Treatment of Oligometastatic Prostate Cancer

Predictive Value of Genomic Classifier Scores and Transcriptomic Data for Prostate Cancer Distant Metastasis Risk: A Multicenter Retrospective Study

Clinical Usefulness of PSMA PET/CT Imaging in Patients with Suspected Recurrence of Prostate Cancer after Primary RT with PSA below the Phoenix Criteria Threshold: Systematic Review and Meta-Analysis

Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials

French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC)

Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post-Hoc Analysis of Two Prospective Ga-68-PSMA PET/CT Imaging Trials

Prognostic Significance of the Risk of Non-localized Disease on PSMA/PET: Comparative Performance of a Novel, PSMA/PET-Derived Risk Stratification Tool for High-Risk Prostate Cancer in a Large, Multi-Institutional Cohort

Stereotactic Radiation Therapy (SRT) for Metastatic Renal Cell Carcinoma (mRCC)

Concurrent Chemoradiation Therapy Versus Acceleration of Radiation Therapy With or Without Concurrent Chemotherapy in Locally Advanced Head and Neck Carcinoma (GORTEC 99-02): 7-Year Survival Data From a Phase 3 Randomized Trial and Prognostic Factors

Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems

Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial

Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications

Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for stages IIB and III esophageal carcinoma: Results of a pilot study

Subcutaneous (SbQ) Versus Intravenous (IV) Administration of Amifostine for Head and Neck (HN) Cancer Patients Receiving Radiotherapy (RT): Preliminary Results of the GORTEC 2000–02 Randomized Trial

Late toxicity results of randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma (GORTEC 94-01)

Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma. final results of the 94-01 GORTEC randomized study

Predictive factors for late toxic effects following high dose rate brachytherapy (HDRB) boost for esophageal cancer (EC)

Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma

Primary chemotherapy and radiosurgical breast-conserving treatment for patients with locally advanced operable breast cancers

2179 Radiation therapy with concomitant weekly docetaxel in stages III and IV non metastatic oral cavity and oropharynx carcinomas. Results of the gortec 98-02 phase II study

Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma. Results of the 94.01 randomized study from the french group of radiation oncology for head and neck cancer (Gortec)

Preoperative or postoperative brachytherapy for patients with endometrial carcinoma stage I and II

Radical hysterectimy for stage I and II endometrial carcinoma : a retrospective analysis of 179 cases

Carcinoma of the uretine cervix stabe IB and early stage II. Prognostic value of the histological tumor regression after initial brachytherapy

Aktive Filter

Suchergebnisse filtern